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        The formation of granulomas at the site of my-
cobacterial infection is an essential component 
of host immunity for controlling infection. This 
process is dependent on the activation of myco-
bacteria-reactive T lymphocytes (  1  ), particularly 
IFN-      –  secreting CD4 and CD8 T cells (  2, 3  ). 
Granuloma formation, however, is a complex 
process that requires not only the activation of 
lymphocytes, but also their recruitment with 
monocytes to the site of the infection, migra-
tion into the tissues, and juxtaposition around 
mycobacteria-infected macrophages (  4  ). This 
colocalization facilitates the activation of bacte-
ricidal mechanisms in infected macrophages by 
T cell  –  derived cytokines (  1  ). Some mycobacte-
ria, however, survive within macrophages, and 
persistent antigenic stimulation perpetuates the 
process, leading to chronic granuloma forma-
tion characterized by dense accumulations of 
infected macrophages, epithelioid cells, and T 
lymphocytes (  5  ). These granulomas contain the 
mycobacterial infection and prevent dissemina-
tion to other organs, but they are also responsi-
ble for lung immunopathology, as the granulomas 
displace and destroy parenchymal tissue (  6  ). One 
of the major roles of the granuloma is to local-
ize and contain not only the bacteria but also 
the infl  ammatory response to the bacteria itself. 
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  D6 is a decoy and scavenger receptor for infl  ammatory CC chemokines. D6-defi  cient mice 
were rapidly killed by intranasal administration of low doses of   Mycobacterium tuberculosis  . 
The death of D6      /      mice was associated with a dramatic local and systemic infl  ammatory 
response with levels of   M. tuberculosis   colony-forming units similar to control D6-profi  cient 
mice. D6-defi  cient mice showed an increased numbers of mononuclear cells (macrophages, 
dendritic cells, and CD4 and CD8 T lymphocytes) infi  ltrating infl  amed tissues and lymph 
nodes, as well as abnormal increased concentrations of CC chemokines (CCL2, CCL3, CCL4, 
and CCL5) and proinfl  ammatory cytokines (tumor necrosis factor     , interleukin 1    , and 
interferon     ) in bronchoalveolar lavage and serum. High levels of infl  ammatory cytokines in 
D6      /      infected mice were associated with liver and kidney damage, resulting in both liver 
and renal failure. Blocking infl  ammatory CC chemokines with a cocktail of antibodies re-
versed the infl  ammatory phenotype of D6      /      mice but led to less controlled growth of 
  M. tuberculosis  . Thus, the D6 decoy receptor plays a key role in setting the balance between 
antimicrobial resistance, immune activation, and infl  ammation in   M. tuberculosis   infection. 
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and has suggested a role for D6 in controlling the resolution 
of CC chemokine  –  driven infl  ammatory responses. Accord-
ingly, D6      /      mice display exaggerated infl  ammatory responses 
after skin application of phorbol esters (  15  ) and subcutaneous 
injection of complete Freund  ’  s adjuvant (  16  ). In this last 
model, D6      /      mice developed granulomas characterized by 
angiogenesis, extensive leukocyte infi  ltration, and prominent 
areas of necrosis more rapidly and severely than WT coun-
terparts. However, whether D6 plays a similar role in infl  am-
matory responses caused by infectious microorganisms, or 
has a role in the induction of a protective response to infec-
tious agents, is presently unknown. To test this possibility, 
we have studied the course of   M. tuberculosis   infection in 
D6      /      mice. 
    RESULTS   
  Expression of the D6 receptor during 
  M. tuberculosis   infection 
  Preliminarily, we investigated the expression of the D6 receptor 
during  M. tuberculosis   infection. In human lungs and lymph nodes 
from a patient with pulmonary tuberculosis, D6 expression 
was observed in lymphatic endothelial cells and only occasion-
ally in scattered leukocytes (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20070608/DC1). In the mouse, 
qualitative RT-PCR experiments indicated that D6 transcripts 
in the liver, spleen, and lungs do not undergo signifi  cant 
changes at 4, 8, and 12 wk after infection with   M. tuberculosis   
(Fig. S2). These data suggest that D6 is mainly expressed in 
lymphatic endothelial cells, in agreement with previous re-
ports (  17  ), and that its expression does not change appreciably 
during   M. tuberculosis   infection. 
    M. tuberculosis   infection in D6      /      mice 
  To determine whether the D6 receptor plays a role in the 
control of   M. tuberculosis   infection, WT and D6      /      mice 
were infected via the intranasal (i.n.) route with 2,000 CFU. 
This dose did not cause mortality in C57BL/6 mice in our 
study (  Fig. 1 A  ).   However,   M. tuberculosis   infection in D6      /      
mice resulted in increased mortality, with     20% of mice suc-
cumbing by week 8, 50% of mice succumbing by week 12, 
and 100% of mice succumbing at week 16, at which time the 
experiments were terminated (  Fig. 1 A  ). The phenotype of 
D6      /      was dramatic and was found highly reproducible over 
a period of 3 yr in two additional experiments performed on 
a total of 17 mice per group. Despite the exaggerated suscep-
tibility of D6      /      mice to   M. tuberculosis   infection, there was 
no diff  erence between the two groups of mice in bacterial 
loads, as determined by CFU counts in the lung, liver, and 
spleen at 2, 4, 8, and 12 wk after infection (  Fig. 1 B  ). 
  Of note, CFU data at 4, 8, and 12 wk after   M. tuberculosis   
infection were rechecked in two additional independent 
  experiments with three mice per group performed over a 
period of 2 yr, confi  rming the results reported in   Fig. 1 B  . 
We then examined by histology the eff  ect of D6 defi  ciency 
on the infl  ammatory response in the lungs, liver, and spleen. 
Although in WT mice a moderate cellular infi  ltration was 
  Indeed, if immune cells are not tightly controlled within the 
lungs, this could lead to excess infl  ammation. Thus, rigorous 
control of the organization of granulomas is likely necessary to 
prevent immunopathology. In most cases, after the repair of 
an infl  amed or damaged tissue, infl  ammation subsides and 
the tissue returns to its homeostatic norm (  7  ). However, if the 
resolution phase of infl  ammation is ineff  ective, chronic in-
fl  ammatory pathologies may develop (  7, 8  ). Failure to resolve 
ongoing infl  ammation is an invariable key feature of pathol-
ogies, which are typically characterized by the high-level 
expression of infl  ammatory cytokines and chemokines (  9  ). 
Therefore, understanding the resolution phase of transient in-
fl  ammatory responses will probably yield insights into some of 
these chronic infl  ammatory pathologies. 
  TNF-     and the related cytokine lymphotoxin-     (  10  –  13  ) 
are potent proinfl  ammatory cytokines with a wide range 
of activities in both the infl   ammatory and immune re-
sponses, and they play an essential role in host resistance 
against infection with   Mycobacterium tuberculosis   and other 
mycobacteria (  10  –  12  ). TNF-      –  defi  cient mice infected by 
aerosol with   M. tuberculosis   develop normal T cell responses 
to mycobacterial antigens, but because of the failure of gran-
uloma formation in the infected organs they are profoundly 
susceptible to the infection, succumbing with extensive ne-
crosis in the lungs and infected organs (  12  ). Other than 
TNF-    , the role of other soluble mediators in regulating 
granuloma formation and persistence is poorly understood. 
Chemokines and their receptors are involved in cell migra-
tion and are logical candidates for a role in granuloma for-
mation, although their expression has been studied to a limited 
degree in   M. tuberculosis   infection (for review see reference 
  14  ). In general, the production of chemokines at a certain 
level may be a factor in preventing cell movement out of 
the granuloma. 
  Recently, studies of the D6 chemokine receptor (for re-
view see reference   9  ) have provided novel insights regarding 
the mechanism of chemokine removal from infl  amed sites. 
D6 is structurally similar to the other chemokine receptors, 
and is most homologous to CCR4 and CCR5. However, 
several properties set D6 apart from other CCRs. First, D6 is 
extremely promiscuous, recognizing 15 chemokines. Inter-
estingly, all D6 ligands are infl  ammatory CC chemokines, 
whereas constitutive CC chemokines, as well as chemokines 
of other subfamilies, are not recognized. Thus, D6 is a pro-
miscuous receptor with selectivity for infl  ammatory CC che-
mokines. Second, the D6 expression pattern is unusual, with 
the predominant expression sites being trophoblasts in the 
placenta and lymphatic endothelial cells in the skin, gut, and 
lung. Third, and most crucially, D6 does not signal in re-
sponse to the binding of any of its ligands. Conversely, the 
only apparent function of D6 is to convey the entire ligand  –
  receptor complex intracellularly, target the chemokine for 
degradation, and recycle the receptor to the membrane. This 
observation, together with the ability of D6 to bind most in-
fl  ammatory CC chemokines, has resulted in the proposal that 
D6 functions as a   “  scavenging  ”   or   “  decoy  ”   receptor (  9, 15  ), JEM VOL. 205, September 1, 2008 
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showed a diff  use liver necrosis in D6      /      mice when com-
pared with WT mice (  Fig. 1 C  ). In agreement with the his-
tology results, at 12 wk after   M. tuberculosis   infection, serum 
seen at 12 wk after infection and most of the lung airspace 
remained intact, an exaggerated response was evident in sur-
viving D6      /      mice (see   Fig. 5 A  ). Histological analysis also 
    Figure 1.           M. tuberculosis   infection in D6      /      mice.   (A) Survival curve of WT (closed squares) and D6     /     (open squares) mice infected i.n. with 
2   ×   10 3   CFU   M. tuberculosis   ( n   = 10). Data indicate the percentage of surviving mice over time. The difference in the survival rates of WT and D6     /    
mice was statistically signifi  cant (P   <   0.001). (B) The course of   M. tuberculosis   infection in WT (closed squares) and D6     /     (open squares) mice in-
fected i.n. with 2   ×   10  3   CFU   M. tuberculosis   and followed against time in the lungs, liver, and spleen. Data shown are the mean bacterial counts   ±   SD. 
Differences between WT and D6     /     mice were not statistically signifi  cant at any time point. (C) Liver and kidney sections from WT and D6     /     mice  at 
12 wk after infection with   M. tuberculosis  . Hematoxylin and eosin staining is shown. Bars, 250   μ  m. Insets show magnifi  ed structures. Original magni-
fi  cation was 100  ×   for the main images and 400  ×   for the insets. (D) Transaminase (ALT and AST) levels are shown. (E) BUN and proteinuria values are 
shown. Similar results were obtained in fi  ve different experiments (shaded bars, WT mice; open bars, D6     /     mice). Differences between WT and D6     /     mice 
were highly statistically signifi  cant (P   <   0.001). Data are the mean   ±   the SD.     2078 ROLE OF THE CHEMOKINE RECEPTOR D6 IN TUBERCULOSIS   | Di Liberto et al. 
35% of CD8 T cells expressed the same activation markers in 
WT mice, although diff  erences were not statistically signifi  -
cant (unpublished data). Similar fi  ndings were also detected 
in the liver, although the diff  erences between D6      /      and WT 
mice were lower than in the lungs and generally reached sig-
nifi  cance at 8 and 12 wk after infection (  Fig. 2 B  ). 
  Cell migration to lymph nodes 
  Because of the fi  nding that the lungs of D6      /      mice con-
tained more macrophages and T lymphocytes than the lungs 
of WT mice, we asked whether a greater number of these 
cells migrated from the lungs to the draining lymph nodes. 
To investigate this possibility, fl  ow cytometric analysis was 
performed on the mediastinal lymph nodes of D6      /      and 
WT mice after   M. tuberculosis   infection. As shown in   Fig. 2 C  , 
the number of macrophages showed a signifi  cant increase in 
the lymph nodes of D6      /      mice at 4 wk after infection. At 
4 and 8 but not 12 wk after infection, there were also statisti-
cally signifi  cant diff  erences in the total number of DCs in the 
lymph nodes of D6      /      mice. The numbers of CD4 and CD8 
T lymphocytes were signifi  cantly higher in the lymph nodes 
of D6      /      mice at 4 and 8 wk after infection, but although the 
latter constantly increased, the former peaked at week 4 and 
then decreased. The increased migration of DCs and T lym-
phocytes to the lymph nodes was expected to result in increased 
numbers of primed T lymphocytes, followed by migration to 
the lungs. ELISPOT analysis confi  rmed this hypothesis, show-
ing that signifi  cantly more CD4 and CD8 T lymphocytes 
from the lungs of D6      /      mice were primed to produce IFN-     
when stimulated by bacille Calmette-Gu  é  rin (BCG)  –  infected 
DCs (  Fig. 3  ).   
transaminases were abnormally increased in D6      /      compared 
with WT mice (  Fig. 1 D  ). Areas of focal necrosis and mono-
nuclear cell infi  ltrates were also evident in the kidneys (  Fig. 
1 C  ), and consistent with this, at 12 wk after   M. tuberculosis   
infection renal function was also severely compromised 
in D6      /      mice, which had signifi  cantly higher blood urea 
nitrogen (BUN) levels and frequency of severe proteinuria 
as compared with WT mice (  Fig. 1 E  ). Of note, although 
  M. tuberculosis   growth occurred in the liver (  Fig. 1 B  ), we 
failed to detect   M. tuberculosis   CFU in kidneys of both WT 
and D6      /      mice over a 12-wk period (not depicted). Thus, 
despite the successful control of the growth of the infect-
ing mycobacteria, D6 defi  ciency led to increased mortality 
associated with lung infl  ammation and combined renal and 
liver failure. 
  Leukocyte infi  ltration in tissues during   M. tuberculosis   
infection in D6      /      mice 
  We examined the cellular infi  ltrate in the lungs and liver of 
D6      /      mice after   M. tuberculosis   infection. At predetermined 
time points, organs were removed, the total number of cells 
was calculated, and fl  ow cytometric analysis was performed to 
determine cell populations (  Fig. 2  ).   Numbers of DCs (F4/80        
and CD11c  +  ) in the lungs (  Fig. 2 A  ) were not signifi  cantly 
diff  erent between D6      /      and WT mice. The numbers of 
macrophages and CD4 and CD8 lymphocytes were signifi  -
cantly higher in D6      /      mice at all time points after infec-
tion. Approximately 45% of CD4 and CD8 T cells infi  ltrating 
the lungs of   M. tuberculosis    –  infected D6      /      mice at 8 and 
12 wk after infection expressed activation markers (CD25  high  , 
CD44  high  , and CD62L  low  ), whereas only 30% of CD4 and 
    Figure 2.         Leukocyte recruitment to tissues and lymph nodes after infection with   M. tuberculosis  .   Leukocytes were isolated from the lungs 
(A), livers (B), and mediastinal lymph nodes (C) of WT (closed squares) and D6     /     (open squares) mice and analyzed by fl  ow cytometry at different 
times after infection with   M. tuberculosis  . The cells were stained with fl  uorescent antibodies to F4/80 (macrophages), CD11c (bright; DCs), CD4, 
and CD8. Shown are the mean cell numbers   ±   SD for each cell type. Similar results were obtained in fi  ve different experiments. *, P   <   0.001; 
**, P   <   0.01.     JEM VOL. 205, September 1, 2008 
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and CCL5/regulated on activation, normal T cell expressed 
and secreted (RANTES) were also signifi  cantly increased in 
the serum of D6      /      mice at 12 wk after infection (  Fig. 4 B  ). 
Control of   M. tuberculosis   infection depends on the activation 
of macrophages by IFN-     and TNF-    , leading to the induc-
tion of inducible NO synthase and the production of reactive 
nitrogen intermediates such as NO. TNF-     is reported to be 
essential for the early expression of mRNA encoding CC and 
CXC chemokines, the initial recruitment of CD4 T lympho-
cytes, and the formation and maintenance of the granulomas 
(  12, 19, 20  ). To determine whether these components of the 
  Chemokine and cytokine levels in D6      /      mice 
  Previous studies have shown that exacerbated infl  ammation in 
mice lacking the D6 receptor is associated with higher levels 
of chemokines in blood and tissues (  15, 16, 18  ). We therefore 
examined chemokine levels in the bronchoalveolar lavage 
(BAL) and serum of   M. tuberculosis    –  infected mice. As shown 
in   Fig. 4 A  , the concentrations of all tested chemokines were 
signifi  cantly higher in the BAL of D6      /      than of WT mice at 
12 wk after infection.   Similarly, concentrations of CCL2/
monocyte chemotactic protein 1 (MCP-1), CCL3/macro-
phage infl  ammatory protein 1     (MIP-1    ), CCL4/MIP-1    , 
    Figure 3.         IFN-      –  producing CD4 and CD8 T cells in the lungs after infection with   M. tuberculosis  .   Lung leukocytes were isolated from WT 
(closed squares) and D6     /     (open squares) mice at the indicated time points after infection and were restimulated in vitro with irradiated BCG-infected 
WT DCs for 36  –  40 h at 37  °  C. The numbers of IFN-      –  producing CD4 and CD8 T cells were quantifi  ed by ELISPOT at the indicated weeks. The mean 
numbers   ±   SD of IFN-      –  producing CD4 and CD8 T cells from WT and D6     /     mice at each time point are shown. Similar results were obtained in fi  ve 
different experiments. *, P   <   0.005; **, P   <   0.01.     
    Figure 4.         Chemokine and cytokine levels in the BAL and serum of   M. tuberculosis    –  infected WT and D6      /      mice.   WT (shaded bars) and D6     /    
(open bars) mice were infected i.n. with   M. tuberculosis  , and BAL or sera were obtained 12 wk later. The levels of CC chemokines (A and B) and cytokines 
(C and D) were measured by ELISA. Shown are the mean values   ±   SD. Similar results were obtained in three different experiments. *, P   <   0.001; **, P   <   0.01.     2080 ROLE OF THE CHEMOKINE RECEPTOR D6 IN TUBERCULOSIS   | Di Liberto et al. 
ing the effi   cacy of the blocking. Conversely, D6      /      mice 
treated with control antibody had very high levels of serum 
chemokines, as did untreated D6      /      mice. TNF-    , IL-1    , 
and IFN-     levels in serum were also consistently reduced by 
treatment with antibodies to CC chemokines (Table S1), and 
cellular infl  ux to the infected tissues signifi  cantly decreased 
(unpublished data). Additionally, both renal and liver func-
tion appeared improved by this treatment, as suggested by 
the low levels of serum transaminases and BUN, and by the 
low proteinuria detected in these mice (Table S1). Over-
all, the most impressive consequence of the neutralization 
of CC chemokines in D6      /      mice was a signifi  cantly pro-
longed survival, as demonstrated by the only 10% mortality 
at 12 wk and 30% mortality at 16 wk after infection with 
  M. tuberculosis   (  Table I  ).   However, in spite of the ability of 
chemokine-blocking antibodies to reduce the overall infl  am-
matory response (  Fig. 5 A  ), the ability of D6      /      mice treated 
in this manner to control the growth of   M. tuberculosis   in the 
lungs was impaired, with higher CFU counts found at 8 and 
12 wk (  Fig. 5 B  ).   This result therefore indicates that the D6 
receptor plays a crucial role in   M. tuberculosis   infection, and in 
the balance between immunopathology and protective im-
mune responses. 
    DISCUSSION   
  A better understanding of the immunological mechanisms of 
pathogenesis and protection is of essential importance for the 
design of novel vaccines and immunotherapies against tuber-
culosis. It has been proposed that the protective response to 
  M. tuberculosis   infection requires CD4 and CD8 lymphocytes, 
the Th1-type cytokines IFN-     and TNF-    , and activated 
macrophages (for review see reference   21  ). The cooperation 
between the cells and cytokines requires close interaction, 
which is achieved after migration and granuloma formation 
in the lungs. The hallmark of infection in the lung is granuloma 
formation, consisting of clusters of macrophages, lympho-
cytes, and DCs, which physically contains the mycobacteria 
and creates a microenvironment for immune cell interaction, 
limiting   M. tuberculosis   growth and dissemination. Chemo-
kines are potent leukocyte activators and chemoattractants 
aiding granuloma formation and thought to be critical for the 
immune response to   M. tuberculosis   (  14  ). In vitro experiments 
demonstrated that   M. tuberculosis   infection of bone marrow  –
  derived mouse macrophages results in the expression of 
TNF-    , as well as several chemokines, including ligands for 
the chemokine receptors CXCR3, CCR5, and CCR2. Neu-
tralization of TNF-     by using antibody or TNFR1-defi  cient 
macrophages demonstrated that expression of certain chemo-
kines (CXCL9/monokine induced by IFN-    , CXCL10/
IFN-inducible protein 10, CXCL11/IFN-inducible T cell      
chemoattractant, CCL5/RANTES, and CCL2/MCP-1) af-
ter   M. tuberculosis   infection was dependent, at least in part, on 
TNF-    . However, the lack of TNF-     did not completely 
abrogate chemokine expression, indicating that there are 
other factors, induced as a result of infection, that stimulate 
chemokine production (  22  ). 
antimycobacterial immune response were aff  ected by D6 de-
fi  ciency, ELISA was performed on the BAL and serum of 
  M. tuberculosis    –  infected mice at 8 (unpublished data) and 12 wk 
after infection. Concentrations of TNF-    , IL-1    , and IFN-     
were signifi  cantly higher in the BAL (  Fig. 4 C  ) and serum 
(  Fig. 4 D  ) of   M. tuberculosis    –  infected D6      /      mice at all tested 
time points, as compared with infected WT mice. Thus, 
  M. tuberculosis   infection in the presence of D6 defi  ciency 
causes a local and systemic infl  ammatory response charac-
terized by increased levels of proinfl  ammatory chemokines 
and cytokines. 
  Neutralization of chemokines in D6      /      mice in vivo reverses 
pathology but increases susceptibility to infection 
  The results in the previous paragraph clearly show that 
  M. tuberculosis   infection in the absence of the D6 receptor is 
characterized by an exaggerated infl  ammatory response and 
increased mortality, despite the successful control of bacterial 
growth. To investigate whether the highly increased levels 
of chemokines observed in D6      /      mice were involved in 
the pathogenesis, we attempted to block infl  ammatory che-
mokines in vivo. For this purpose, mice were treated with a 
mixture of antibodies to the CC chemokines CCL2/MCP-
1, CCL3/MIP-1    , CCL4/MIP-1    , and CCL5/RANTES, 
as previously described (  15, 18  ), or with antibodies to each 
individual chemokine. On the same days, control mice re-
ceived i.p. injections of an equivalent amount of irrelevant 
antibodies. Mice were injected weekly with   M. tuberculosis  , 
starting from the third week after infection. Following this 
treatment schedule, CCL2/MCP-1, CCL3/MIP-1   , CCL4/
MIP-1    , and CCL5/RANTES production in the serum of 
D6      /      mice was consistently reduced (Table S1, available at 
http://www.jem.org/cgi/content/full/jem.20070608/DC1), 
even below levels detected in WT mice, thus demonstrat-
    Table I.        Effects of treatment with anti  –  CC chemokine 
antibodies on the survival of D6     /     mice 
to   M. tuberculosis   infection 
Weeks after infection
Mice Treatment 8 12 16
WT Nil 0/10 0/10 0/10
D6      /     Nil 3/10 5/10 9/10
D6      /     Control antibody 2/10 4/10 9/10
D6      /     Anti-CCL2/MCP-1 3/10 3/10 8/10
D6      /    Anti-CCL3/MIP-1    4/10 6/10 9/10
D6      /    Anti-CCL4/MIP-1    2/10 4/10 8/10
D6      /     Anti-CCL5/RANTES 2/10 4/10 9/10
D6      /     Mix antibody 0/10* 1/10* 3/10**
WT mice and D6     /     mice either untreated or treated with monoclonal antibodies 
to single individual CC chemokines, or with a cocktail of anti  –  CC chemokines (mix 
antibody) or irrelevant control antibodies, were infected with   M. tuberculosis . 
Mice were scored for survival over time. Data shown are the numbers of deaths 
out of the number of treated mice (  n   = 10 per group). *, P   <   0.001; and **, P   <   
0.01 when compared with values in D6     /     mice either untreated (Nil) or treated 
with control antibody.JEM VOL. 205, September 1, 2008 
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  The action of chemokines is tightly controlled by decoy 
receptors (  9  ), which internalize and target chemokines for 
intracellular degradation, thus avoiding excessive infl  amma-
tory responses and the consequent tissue damage. D6 is a 
decoy receptor that recognizes most infl  ammatory CC che-
mokines, implying that it may play a key role in resolving 
CC chemokine  –  driven infl  ammatory responses. The results 
reported in this paper confi  rm this possibility in a mouse 
model of   M. tuberculosis   infection through the mucosal (i.n.) 
route and show that D6      /      mice have an exaggerated infl  am-
matory response leading to death, despite their ability to effi   -
ciently control bacterial load. Upon i.n. delivery of low-dose 
  M. tuberculosis  , 20% of mice succumbed at week 8, 50% of 
mice succumbed at week 12, and 100% of mice succumbed 
at week 16, despite the successful control of the growth of 
  M. tuberculosis   bacilli. The phenotype of D6      /      was dramatic and 
was found highly reproducible over a period of 3 yr in two 
additional experiments performed on a total of 17 mice per 
group. Moreover, CFU data at 4, 8, and 12 wk after   M. tu-
berculosis   infection were found highly reproducible in two ad-
ditional independent experiments performed over a period of 
2 yr. Mortality in D6      /      mice coincided with an overwhelm-
ing local and systemic infl   ammatory response that mainly 
compromised liver and kidney functions in the host, charac-
terized by increased and sustained numbers of macrophages, 
DCs, and CD4 and CD8 T lymphocytes, and increased 
production of infl  ammatory CC chemokines and cytokines 
(TNF-    , IL-1    , and IFN-    ). However, we failed to detect 
  M. tuberculosis   CFU in kidneys of both WT and D6      /      mice 
over a 12-wk period. This might refl  ect either   M. tuberculosis   
growth below the CFU detection limit or the development 
of kidney damage in the absence of kidney infection. A simi-
lar increase in macrophage, DC, and T cell numbers was 
detected in the mediastinal lymph nodes, suggesting the 
possibility that more T lymphocytes were being primed and 
migrating to the lungs. Such increased priming likely ac-
counts for the substantially increased numbers of T lympho-
cytes migrating to the lungs of D6      /     mice after   M. tuberculosis   
infection, as confi  rmed by ELISPOT analysis showing that 
signifi  cantly more CD4 and CD8 T lymphocytes from the 
lungs of D6      /      mice were primed to produce IFN-     when 
stimulated in vitro by BCG-infected DCs. The fi  nding that 
D6      /      mice had more infl  ammation is intriguing and con-
vincingly supports an immunoregulatory role for the D6 re-
ceptor. Recent data in other systems have shown that D6      /      
mice display exaggerated responses to infl  ammatory stimuli, 
resulting in an aggressive cutaneous infl  ammatory pathology 
after the application of phorbol esters (  15  ). In another study 
(  16  ), D6      /      mice displayed an exaggerated response to the 
subcutaneous injection of complete Freund  ’  s adjuvant. Un-
fortunately, none of these studies has been able to defi  ne 
a mechanism for the heightened immune response in the 
D6      /      mice. Although there are several diff  erent possibilities 
for the increased infl  ammatory response in   M. tuberculosis    –
  infected D6      /      mice, the one we favor is that lack of the D6 
receptor fails to remove CC chemokines from many diff  erent 
  In mouse models, gene expression of CXC and CC che-
mokines has been detected in the lungs after   M. tuberculosis   
infection (  22  –  24  ). CXCR3-defi  cient mice (  25  ) have an im-
paired granuloma formation after aerosol infection with   M. 
tuberculosis  , although this eff  ect is transient, occurring at the 
early stages of infection. CCR2-defi  cient mice are extraordi-
narily susceptible to moderate- or high-dose   M. tuberculosis   
administered i.v. (  26  ), and susceptibility is dose-dependent 
(  27  ). Conversely, CCR5 (  28  ) may not be essential to the de-
velopment of a protective response to   M. tuberculosis   infection. 
CCL2/MCP-1  –  defi  cient mice did not demonstrate an in-
creased susceptibility to   M. tuberculosis   infection, but whether 
cell infi  ltration or histology was aff  ected in these mice was not 
reported (  29, 30  ). However, transgenic mice overexpressing 
CCL2/MCP-1 were more susceptible to tuberculosis (  31  ). 
    Figure 5.           M. tuberculosis   growth in D6      /      mice treated with anti  –
  CC chemokine antibodies.   (A) WT mice and D6     /     mice either untreated 
(Nil), or treated with a cocktail of anti  –  CC chemokine (Anti-CC Ab) or irrel-
evant control antibodies (Control Ab), were infected with   M. tuberculosis . 
Granulomatous infi  ltration in the lungs of   M. tuberculosis  – infected  mice 
was assessed by analyzing two lung lobes from each mouse. Data are ex-
pressed as the percentage   ±   SD of the lung area involved, calculated by 
dividing the granuloma-involved area by the total tissue area. A representa-
tive of two different experiments is shown. (B) The course of   M. tuberculosis  
infection followed against time in lungs. WT mice and D6     /     mice  either 
untreated (Nil), or treated with antibodies against individual chemokines, 
with a cocktail of anti  –  CC chemokine (Mix Ab), or with irrelevant control 
antibodies (Control Ab), were infected with   M. tuberculosis  . Data shown are 
the mean bacterial counts   ±   SD. *, P   <   0.01 when compared with CFU val-
ues in D6     /     mice either untreated (Nil) or treated with control antibody.    2082 ROLE OF THE CHEMOKINE RECEPTOR D6 IN TUBERCULOSIS   | Di Liberto et al. 
infl  amed tissue, may favor resolution of chronic infl  amma-
tory responses and overall provide a fi  ne mechanism for the 
control of the balance between protective immune responses 
and immunopathology. 
  MATERIALS AND METHODS 
  Mice.     D6      /      mice were generated as previously described (  15  ). Homoge-
neous populations were established by backcrossing heterozygous mice to 
C57BL/6 mice for more than eight generations. The resultant heterozygous 
mice were bred to obtain homozygotes. WT C57BL/6J and D6      /      mice 
were bred in a specifi  c pathogen-free/viral antibody  –  free barrier facility and 
obtained from Charles River Laboratories. 8  –  14-wk-old male and female 
mice were used in accordance with institutional guidelines in compliance 
with national (D.L. N.116, Gazzetta Uffi   ciale della Repubblica Italiana, sup-
plement 40, 18-2-1992) and international law and policies (European Eco-
nomic Community Council, 1987, Directive 86/609, Offi   cial Journal of 
European Communites L 358,1; and Institute of Laboratory Animal Re-
sources, Committee on Life Sciences, National Research Council, 1996, 
Guide for the Care and Use of Laboratory Animals). Each experimental 
group consisted of 7  –  10 mice. All infected mice were maintained under 
germ-free conditions and were routinely monitored for mouse pathogens. 
Experiments were performed in specifi  c pathogen-free facilities. 
  Chemicals and reagents.     All chemicals were purchased from Sigma-
Aldrich, unless otherwise noted. Middlebrook 7H9 liquid medium and 7H10 
agar were obtained from Difco Laboratories. Antibodies used in fl  ow cytom-
etry were obtained from BD Bioscience or R  &  D Systems. 
    M. tuberculosis   and infection of mice.     Mice were infected via the i.n. 
route with   M. tuberculosis   H37Rv (2   ×   10  3   CFU in 20   μ  l). This resulted in 
reproducible delivery of 50  –  100 viable CFU   M. tuberculosis  , as confi  rmed 
by CFU determination on the lungs of infected mice 1 d after infection. In 
fact, in a total of 10 mice per group from four independent experiments, 
day 1   M. tuberculosis   CFU ranged from 50 to 100 (with only one exception 
in one WT mouse of 110 CFU), and in any case no statistical signifi  cant 
diff  erences between day 1 CFU in WT (72.5   ±   21) and D6      /      (75   ±   19) 
mice were detected (P = 0.9658 by the Student  ’  s   t   test). Moreover, using 
the i.n. infection route, we failed to detect   M. tuberculosis   CFU in nasal tis-
sues in two diff  erent experiments. The tissue bacillary load was quantifi  ed 
by plating serial dilutions of the lung, liver, and spleen homogenates into 
7H10 agar, as described previously (  34  ). 
  Flow cytometric analysis of tissue cells.     To determine cellular infi  ltrate, 
the lungs, liver, and mediastinal lymph nodes were removed at diff  erent 
weeks after infection and digested in the presence of 200 U/ml of collage-
nase, and mononuclear cell suspensions were obtained through Lympholyte 
M (Cederlane Laboratories) gradient centrifugation. The viability of cells, as 
determined by Trypan blue exclusion, was   >  90%. A single-cell suspension 
was prepared by pushing the tissue through a cell strainer. In some experi-
ments, lung mononuclear cells were enriched in T cells by passage through 
a nylon wool column, and CD4 and CD8 T cells were then sorted by anti-
CD4 or -CD8 immunomagnetic beads (Miltenyi Biotec), according to the 
manufacturer  ’  s instructions (  34  ). The cells were incubated for 24 h at 37  °  C 
in complete medium to allow cells and beads to dissociate. Single-cell sus-
pension were counted. The samples were triple stained with fl  uorochrome-
conjugated anti-CD3, -CD4, -CD8, -CD44, -CD62L, -CD25, -CD11c, 
and -F4/80, in FACS buff  er (0.1% Na azide, 0.1% BSA, and 20% mouse se-
rum). Purifi  ed or PE-, FITC-, CyChrome-, or allophycocyanin-conjugated 
isotype control Igs were used as controls. After washes, the cells were fi  xed 
in 4% paraformaldehyde for 1 h and collected on a FACSCalibur (BD Bio-
sciences). Analysis was performed on CellQuest software (BD Biosciences). 
  ELISPOT analysis for IFN-    .     The ELISPOT method (  35  ) was used to 
detect IFN-     secretion by individual CD4 or CD8 T cells from infected 
organs and tissues, determining their increased concentration. 
Such increased expression/circulation of CC chemokines 
may, in turn, lead to signaling through their receptors and 
could result in the infl  ux of immune cells and abundant, un-
controlled production of proinfl  ammatory cytokines, which 
ultimately mediate tissue damage. However, the increased 
expression may also have been a reaction to the numbers of 
cells in infected organs. Whatever the case, the concentra-
tions of CCL2/MCP-1, CCL3/MIP-1    , CCL4/MIP-1    , 
and CCL5/RANTES were found to be highly increased in 
the BAL and serum of   M. tuberculosis    –  infected D6      /      mice 
and sustained over time; moreover, blocking all four of them 
in D6      /      mice in vivo (CCL2/MCP-1, CCL3/MIP-1    , 
CCL4/MIP-1    , and CCL5/RANTES) by repeated injec-
tion of a cocktail of neutralizing antibodies signifi  cantly re-
duced cell recruitment, production of proinfl  ammatory CC 
chemokines and cytokines, liver and kidney damage, and, 
most importantly, the mortality of D6      /      mice. However, 
despite controlling infl  ammatory responses, these mice be-
came more susceptible to infection with   M. tuberculosis  , as 
demonstrated by higher CFU counts in the lungs at 8 and 12 
wk after infection. The data reported in   Table I   clearly show 
that none of the neutralized chemokines alone accounts for 
the reduced infl  ammatory response and mortality, and for the 
increased susceptibility to infection. 
  CCL3/MIP-1    , CCL4/MIP-1    , and CCL5/RANTES 
are all ligands of CCR5, which can attract and activate mac-
rophages and Th1 lymphocytes. However studies in CCR5      /      
mice have found that although CCR5 plays a role in the mi-
gration of DCs to and from lymph nodes (  28, 32  ), it is not in-
dispensable for granuloma formation and immune protection 
against   M. tuberculosis   infection (  32  ). CCL5/RANTES has 
been associated with the generation of type 1 cytokine  –  pro-
ducing granulomas (  33  ). CCR2-defi  cient mice are extraordi-
narily susceptible to moderate- or high-dose   M. tuberculosis   
administered i.v. but not to low aerosol doses (  27  ), and CCL2/
MCP-1  –  defi  cient mice do not demonstrate an increased sus-
ceptibility to   M. tuberculosis   infection (  29  ). However, there is 
redundancy in the chemokine system. Specifi  c to this study, the 
chemokines CCL2/MCP-1, CCL3/MIP-1    , CCL4/MIP-1    , 
and CCL5/RANTES are ligands of CCR5, but CCL3/MIP-
1     and CCL5/RANTES can also signal through CCR1 and 
CCR3. This fi  nding makes it diffi   cult to dissect the precise 
roles of individual chemokines and their receptors. In this 
study, enhancing the type 1 T cell response or the ability of 
T lymphocytes to enter the lungs over the WT level does not 
have an obvious benefi  cial eff  ect on the control of infection 
and infl  ammation, indicating that there are additional factors 
that must be induced or enhanced to increase the ability of the 
host to eliminate   M. tuberculosis   infection. 
  In summary, our study suggests an important role for 
the D6 receptor in immune regulation. D6 controls chemo-
kine accumulation and activity, migration, and possibly, the 
maintenance of DCs and T cells in infected organs, as well 
as the production of infl  ammatory cytokines. Therefore D6, 
through its ability to avoid an excess of chemokines in the JEM VOL. 205, September 1, 2008 
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determine the statistical signifi  cance of the diff  erences in survival times of 
WT and D6      /      mice. The signifi  cance of diff  erences of log  10   CFU counts 
between groups was determined using one-way analysis of variance 
(ANOVA), with Scheff  e tests for post-ANOVA individual comparisons. P   <   
0.05 was considered signifi  cant. 
  Online supplemental material.     Fig. S1 shows lung and draining lymph 
nodes sections from   M. tuberculosis   patients stained for D6 and the macro-
phage marker CD68. Fig. S2 shows expression levels of the D6 transcript in 
mouse tissues during   M. tuberculosis   infection. Table S1 reports the eff  ects 
of treatment of D6      /      mice with anti  –  CC chemokine antibodies. Online 
supplemental material is available at http://www.jem.org/cgi/content/full/
jem.20070608/DC1. 
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mice, after stimulation with BCG-infected DCs in vitro prepared as previ-
ously described (  36  ). In brief, ELISPOT plates (BD Biosciences) were 
coated with IFN-     capture antibody overnight at 4  °  C. The capture anti-
body was discarded, and the plates were washed and blocked with com-
plete media for 2 h at room temperature. 150,000 purifi  ed CD4 or CD8 T 
cells per well were cultured with irradiated BCG-infected WT DCs for 
36  –  40 h at 37  °  C. The cells were discarded, and plates were washed with 
deionized water and PBS/Tween 20. Secondary biotinylated antibody was 
added for 2 h and incubated at room temperature, followed by washing 
with PBS/Tween 20. Streptavidin-alkaline phosphatase was added to the 
plates for 1 h, followed by washing and development of a color reaction 
using the AEC substrate reagent kit (BD Biosciences). The reaction was 
stopped when spots developed by running the plate under water. The spots 
were enumerated using an ELISPOT reader (Bioreader 3000; BioSys). 
  ELISA for cytokines and chemokines.     BAL was obtained by fl  ushing 
2 ml PBS into the lungs of killed mice (  37  ). The concentrations of chemo-
kines (CCL2/MCP-1, CCL3/MIP-1    , CCL4/MIP-1    , CCL5/RANTES, 
CCL11/eotaxin, and CCL22/MDC) and cytokines (TNF-     and IFN-    ) 
were quantifi  ed by ELISA in BAL and sera using commercially available 
kits (R  &  D Systems). 
  Determination of serum transaminases, BUN, and proteinuria.   
  Serum alanine aminotransferase (ALT; EC 2.6.1.2) and aspartate amino-
transferase (AST; EC 2.6.1.1) were measured by the standard photometric 
method using an automatic analyzer (type 7350; Hitachi Chemical Diagnos-
tics) and a commercial kit (Sigma-Aldrich) adapted to small-sample volumes, 
as previously described (  38  ). The normal ranges of ALT and AST were ob-
tained testing sera from 10 mice, age- and sex-matched with animals used in 
experimental groups (  38  ). Proteinuria was measured on a 0  –  4+ scale using 
a colorimetric assay strip (  38  ) for albumin (Albustix; Bayer): 0, absent; 1+, 
  ≤  30 mg/100 ml (mild); 2+, 100 mg/100 ml (moderate); 3+, 300 mg/100 ml 
(severe); and 4+,   >  2,000 mg/100 ml (severe). BUN levels were measured by 
impregnating Azostix strips (Bayer) with a drop of fresh blood (  38  ) and using 
the following scale: 1+, 5  –  15 mg/100 ml (normal); 2+, 15  –  26 mg/100 ml 
(mild); and 3+,   ≥  30 mg/100 ml (severe). 
  Neutralization of chemokines in vivo.     To block infl  ammatory chemo-
kines, mice were treated with a mixture of goat antibodies to the CC che-
mokines CCL2/MCP-1, CCL3/MIP-1    , and CCL4/MIP-1    ), and a 
monoclonal antibody to CCL5/RANTES purchased lyophilized from R  &  D 
Systems, resuspended in sterile PBS, and mixed as previously described (  16, 
18  ). Mice were given i.p. injections of 200   μ  l of the mixture, equivalent to 
100   μ  g of each antibody. Alternatively, mice were treated with 400   μ  g of in-
dividual antibodies specifi  c for a single CC chemokine. On the same days, 
control mice received i.p. injections equivalent to 400   μ  g of irrelevant anti-
bodies (normal goat IgG; Sigma-Aldrich) in 200   μ  l PBS. Mice were injected 
weekly, starting from the third week after infection with   M. tuberculosis  . 
  Histology and morphometry.     Tissue samples for histological studies 
were fi  xed in 10% normal buff  ered formalin, followed by paraffi   n embed-
ment. 5  –  6-  μ  m sections were stained with hematoxylin and eosin. For 
histometry, 5-  μ  m-thick sections from each specimen were stained with 
  hematoxilin and eosin and photographed at 6  ×   using a stereoscopic zoom 
microscope (SMZ800; Nikon) and a digital camera (Coolpix 990; Nikon). 
Sections of at least eight lung lobes were studied in each case. A sequence of 
appropriate software programs were used (Scion Image [Scion Corporation]; 
Photoshop 5.0 [Adobe Systems Inc.]) to determine the area of each single 
lesion and the total tissue area on photomicrographs at each time point. Mea-
surements were done blindly by two independent pathologists (P.J. Cardona 
and N. Caceres). Data are percentages calculated by dividing the granuloma-
involved area by the global tissue area and multiplying by 100. 
  Statistics.     The double-tailed Student  ’  s   t   test was used to compare the sig-
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